These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 16429296)
21. [Treatment of moderate or severe infections using imipenem/cilastatin. 41 cases based on a multicenter protocol]. Stahl JP; Chavanet P; Robert D; Croize J; Mercatello A; Bru JP; Aguilaniu F; Portier H; Micoud M Pathol Biol (Paris); 1986 May; 34(5):465-9. PubMed ID: 3534723 [TBL] [Abstract][Full Text] [Related]
22. Safe use of meropenem in a patient with a possible nonimmediate allergy to imipenem. Lakhal K; Lortat-Jacob B; Neukirch C; Pajot O; Wolff M Pharmacotherapy; 2007 Sep; 27(9):1334-8. PubMed ID: 17723087 [TBL] [Abstract][Full Text] [Related]
23. [Meropenem (Merrem) vs imipenem/cilastatin in hospital treatment of intra-abdominal infections. A multicenter study]. Tonelli F Minerva Chir; 1997 Mar; 52(3):317-26. PubMed ID: 9148225 [TBL] [Abstract][Full Text] [Related]
24. Intramuscular imipenem/cilastatin for treatment of mild and moderately severe bacterial infections. Keller CA; Villavicencio J; Ramirez C Scand J Infect Dis Suppl; 1987; 52():26-31. PubMed ID: 3483287 [TBL] [Abstract][Full Text] [Related]
25. [Pharmacoeconomics of meropenem versus imipenem/cilastatin]. Marquina MC; Giráldez J; Idoate A Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():45-50. PubMed ID: 9410069 [TBL] [Abstract][Full Text] [Related]
26. Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam. Edwards SJ; Wordsworth S; Clarke MJ Eur J Health Econ; 2012 Apr; 13(2):181-92. PubMed ID: 21243514 [TBL] [Abstract][Full Text] [Related]
27. Imipenem/cilastatin in the treatment of severe hospital infections. Patoia L; Menichetti F; Bucaneve G; Pasticci MB; Baratta E; Grignani F; Del Favero A Chemioterapia; 1988 Apr; 7(2):105-8. PubMed ID: 3165056 [TBL] [Abstract][Full Text] [Related]
28. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections. Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761 [TBL] [Abstract][Full Text] [Related]
29. Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation. Lee LS; Kinzig-Schippers M; Nafziger AN; Ma L; Sörgel F; Jones RN; Drusano GL; Bertino JS Diagn Microbiol Infect Dis; 2010 Nov; 68(3):251-8. PubMed ID: 20851549 [TBL] [Abstract][Full Text] [Related]
30. Imipenem/cilastatin: the first carbapenem antibiotic. Lyon JA Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385 [TBL] [Abstract][Full Text] [Related]
31. Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infections. Garau J; Blanquer J; Cobo L; Corcia S; Daguerre M; de Latorre FJ; León C; Del Nogal F; Net A; Rello J Eur J Clin Microbiol Infect Dis; 1997 Nov; 16(11):789-96. PubMed ID: 9447899 [TBL] [Abstract][Full Text] [Related]
32. Meropenem versus imipenem/cilastatin in the treatment of hospitalized patients with skin and soft tissue infections. Nichols RL; Smith JW; Geckler RW; Wilson SE South Med J; 1995 Apr; 88(4):397-404. PubMed ID: 7716590 [TBL] [Abstract][Full Text] [Related]
33. Imipenem/cilastatin versus aminoglycoside plus amoxicillin plus clindamycin in the treatment of serious postoperative infections. Christen D; Buchmann P; Geroulanos S Scand J Infect Dis Suppl; 1987; 52():11-4. PubMed ID: 3331039 [TBL] [Abstract][Full Text] [Related]
34. Cost-effectiveness model of empiric doripenem compared with imipenem-cilastatin in ventilator-associated pneumonia. Zilberberg MD; Mody SH; Chen J; Shorr AF Surg Infect (Larchmt); 2010 Oct; 11(5):409-17. PubMed ID: 20666580 [TBL] [Abstract][Full Text] [Related]
35. Treatment of obstetric and gynecologic infections with meropenem: comparison with imipenem/cilastatin. Maggioni P; Di Stefano F; Facchini V; Irato S; Mancuso S; Colombo M; Massobrio M; Melis GB; Crosignani P J Chemother; 1998 Apr; 10(2):114-21. PubMed ID: 9603636 [TBL] [Abstract][Full Text] [Related]
36. Empiric carbapenem monotherapy in pediatric bone marrow transplant recipients. Nelson WK; Rayback PA; Quinones R; Giller RH Ann Pharmacother; 2002 Sep; 36(9):1360-5. PubMed ID: 12196052 [TBL] [Abstract][Full Text] [Related]
37. Meropenem versus imipenem/cilastatin in intra-abdominal infections requiring surgery. Meropenem Study Group. Geroulanos SJ J Antimicrob Chemother; 1995 Jul; 36 Suppl A():191-205. PubMed ID: 8543495 [TBL] [Abstract][Full Text] [Related]
38. [Comparative clinical and epidemiological evaluation of beta-lactam antibiotics in the treatment of intraabdominal infections]. Beketov AS; Sidorenko SV; Pisarev VV; Komarov RM Antibiot Khimioter; 2003; 48(3):34-41. PubMed ID: 12914120 [TBL] [Abstract][Full Text] [Related]
39. A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients. Cox CE; Holloway WJ; Geckler RW Clin Infect Dis; 1995 Jul; 21(1):86-92. PubMed ID: 7578765 [TBL] [Abstract][Full Text] [Related]
40. Treatment of acute bacterial exacerbations of chronic obstructive pulmonary disease in hospitalised patients--a comparison of meropenem and imipenem/cilastatin. COPD Study Group. Hamacher J; Vogel F; Lichey J; Kohl FV; Diwok K; Wendel H; Lode H J Antimicrob Chemother; 1995 Jul; 36 Suppl A():121-33. PubMed ID: 8543488 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]